60 reports of this reaction
4.3% of all SODIUM NITROPRUSSIDE reports
#3 most reported adverse reaction
INJURY is the #3 most commonly reported adverse reaction for SODIUM NITROPRUSSIDE, manufactured by EXELA PHARMA SCIENCES, LLC. There are 60 FDA adverse event reports linking SODIUM NITROPRUSSIDE to INJURY. This represents approximately 4.3% of all 1,403 adverse event reports for this drug.
Patients taking SODIUM NITROPRUSSIDE who experience injury should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
INJURY is moderately reported among SODIUM NITROPRUSSIDE users, representing a notable but not dominant share of adverse events.
In addition to injury, the following adverse reactions have been reported for SODIUM NITROPRUSSIDE:
The following drugs have also been linked to injury in FDA adverse event reports:
INJURY has been reported as an adverse event in 60 FDA reports for SODIUM NITROPRUSSIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
INJURY accounts for approximately 4.3% of all adverse event reports for SODIUM NITROPRUSSIDE, making it one of the most commonly reported side effect.
If you experience injury while taking SODIUM NITROPRUSSIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.